41
Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette’s Disorder
Condition(s):Tourette’s DisorderLast Updated:January 19, 2018Completed
Treatment Refractory: 11147 Clinical Trials, Page 5 of 1115
Hide Studies Not Open or Pending
42
Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn’s Disease
Condition(s):Crohn’s DiseaseLast Updated:December 8, 2021Completed
43
Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer
Condition(s):Bladder CancerLast Updated:November 6, 2012Unknown status
44
Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer
Condition(s):Colorectal Neoplasms, MalignantLast Updated:October 22, 2020Recruiting
45
The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients
Condition(s):Colitis, UlcerativeLast Updated:January 10, 2023Completed
46
A Pilot Study of Deep Brain Stimulation of the Amygdala for Treatment-Refractory Combat Post-Traumatic Stress Disorder
Condition(s):Post Traumatic Stress DisorderLast Updated:May 29, 2013Withdrawn
47
One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
Condition(s):TumorsLast Updated:October 14, 2016Terminated
48
Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)
Condition(s):Acute Myeloid Leukemia; Myelodysplastic Syndrome; Multiple MyelomaLast Updated:October 22, 2010Completed
49
SEEG-Guided DBS for OCD
Condition(s):Obsessive-Compulsive DisorderLast Updated:February 10, 2023Not yet recruiting
50
Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment Refractory/Intolerant CML Failing ≥3 Prior CML Therapies
Condition(s):Healthy (For Part A); Chronic Myeloid Leukemia (for Part B and C)Last Updated:December 8, 2022Recruiting